Q3 2018 Holdings
Filed 2018-11-14 | 36 holdings | $167.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $44.7M | 579,776 | 26.6% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $42.5M | 2,428,571 | 25.3% |
| Codexis Inc(CDXS) | COM | 192005106 | $34.7M | 2,025,000 | 20.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $23.6M | 270,000 | 14.1% |
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $12.1M | 70,000 | 7.2% |
| Caredx Inc(CDNA) | COM | 14167L103 | $5.8M | 200,000 | 3.4% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $3.8M | 207,500 | 2.3% |
| Loxo Oncology Inc | COM | 548862101 | $61.5K | 360,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $58.5K | 750,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $52.5K | 805,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $44.1K | 312,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $41.5K | 2,550,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $40.2K | 2,400,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $37.7K | 258,000 | 0.0% |
| Spark Therapeutics Inc | COM | 84652J103 | $36.8K | 675,000 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $33.9K | 2,000,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $27.0K | 2,250,818 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $26.2K | 71,500 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $25.7K | 3,500,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $24.7K | 625,000 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $21.5K | 1,135,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $16.7K | 440,000 | 0.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $15.6K | 550,000 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $14.6K | 460,000 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $10.3K | 720,586 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $9.8K | 220,000 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $8.8K | 1,314,743 | 0.0% |
| Orasure Technologies Inc(OSUR) | COM | 68554V108 | $8.1K | 525,000 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $8.0K | 350,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $6.9K | 235,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $6.5K | 40,000 | 0.0% |
| Neogen Corp(NEOG) | COM | 640491106 | $4.6K | 65,000 | 0.0% |
| Celgene Corp(CELG)Call | COM | 151020104 | $4.5K | 50,000 | 0.0% |
| Gilead Sciences Inc(GILD)Call | COM | 375558103 | $3.9K | 50,000 | 0.0% |
| Neon Therapeutics Inc | COM | 64050Y100 | $2.9K | 338,345 | 0.0% |
| Jounce Therapeutics Inc(JNCEEUR) | COM | 481116101 | $2.4K | 375,000 | 0.0% |